Finadyne Paste 10g (pack of 6)

arget species Horse Indications for use For the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. Contra-indications Do not exceed the stated dose or duration of treatment. Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastrointestinal ulceration or bleeding, or where there is hypersensitivity to the product. Do not administer other NSAIDs concurrently or within 24 hours of each other. Do not use in hypovolaemic animals except in the case of endotoxaemia or septic shock. Avoid use in dehydrated, hypovolaemic or hypersensitive animals as there is a potential risk of increased renal toxicity. Special warnings for each target species Non-steroidal anti-inflammatory drugs are not permitted substances under the rules of racing and under rules covering other competitive events. The Royal College of Veterinary Surgeons has given guidance to the Veterinary profession regarding the use of anti-inflammatory drugs in competing horses. It states that if a veterinarian recommends the discontinuation of any such drug not less than eight days before racing he should feel sure he has catered for all but the most exceptional case. Special precautions for use Use in animals less than 6 weeks of age or in aged animals may involve additional risk. If such use cannot be avoided animals may require a reduced dosage and careful clinical management. It is preferable that flunixin is not administered to animals undergoing general anaesthesia until fully recovered. NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infections, appropriate concurrent antimicrobial therapy should be instigated. Special precautions to be taken by the person administering the medicinal product to the animals Avoid contact with eyes and direct contact with skin. Gloves should be worn during application. In the case of accidental contact with eyes, rinse immediately with plenty of water and seek medical advice. The product may cause reactions in sensitive individuals. If you have known hypersensitivity to non-steroidal anti-inflammatory products, do not handle the product. Reactions may be serious. Wash hands and exposed skin after use. Adverse reactions None known. Use during pregnancy, lactation or lay Do not administer to pregnant mares. Safety studies in pregnant mares have not been conducted. Interactions Concurrent administration of potentially nephrotoxic drugs should be avoided. Some NSAIDs may be highly bound to plasma proteins and may compete with other highly bound drugs to produce an increase in non-bound pharmacologically active concentrations which can lead to toxic effects.
Vat Rate: 20%